Propolis as an adjunctive therapy for treatment of uncomplicated cystitis in women: A randomized double-blind placebo-controlled trial

被引:1
|
作者
Shekari, Mahdi [1 ]
Hadi, Amir [2 ]
Daabo, Hamid Mahmood Abdullah [3 ]
Allahyari, Zahra Haj [4 ]
Hjazi, Ahmed [5 ]
Rafie, Nahid [6 ]
Heidari, Mohammad [7 ,8 ]
机构
[1] Qom Univ Med Sci, Fac Med, Dept Nutr, Qom, Iran
[2] Minist Hlth & Med Educ, Food & Drug Adm, Halal Res Ctr IRI, Tehran, Iran
[3] Duhok Polytech Univ, Duhok Tech Inst, Pharm Dept, Duhok, Iraq
[4] Qom Univ Med Sci, Fac Nursing & Midwifery, Dept Nursing, Qom, Iran
[5] Prince Sattam bin Abdulaziz Univ, Coll Appl Med Sci, Dept Med Lab Sci, Al Kharj, Saudi Arabia
[6] Isfahan Univ Med Sci, Food Secur Res Ctr, Sch Nutr & Food Sci, Dept Clin Nutr, Esfahan, Iran
[7] Qom Univ Med Sci, Fac Med, Dept Urol, Qom, Iran
[8] Qom Univ Med Sci, Fac Med, Dept Urol, Qom 3716993456, Iran
关键词
adjunctive therapy; clinical trial; propolis; uncomplicated cystitis; urinary frequency; URINARY-TRACT-INFECTION; ANTIMICROBIAL SUSCEPTIBILITY; ANTIBACTERIAL ACTIVITY; HONEY; OBESITY;
D O I
10.1002/ptr.8053
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The current research is designed to investigate the effect of propolis supplementation on the clinical manifestations in women suffering from uncomplicated cystitis. In this randomized double-blind, placebo-controlled trial, 120 women with uncomplicated cystitis were selected and randomly assigned into two groups to receive two 500 mg capsules of propolis or placebo daily for 7 days along with ciprofloxacin (250 mg). Clinical symptoms including hematuria, urinary frequency, dysuria, suprapubic pain, and urgency, as well as bacteriuria, were assessed before and after the intervention. After supplementation, participants in the intervention group had significantly fewer days of urinary frequency (p < 0.001), dysuria (p = 0.005), and urgency (p = 0.03). However, there was no significant difference between the two groups regarding hematuria and suprapubic pain (p > 0.05). Furthermore, the severity of bacteriuria decreased significantly in both groups. In conclusion, it seems that propolis supplementation in women with uncomplicated cystitis could improve urinary frequency, dysuria, and urgency. However, further clinical trials should be conducted to fully understand the effects of propolis in women suffering from uncomplicated cystitis.
引用
收藏
页码:520 / 526
页数:7
相关论文
共 50 条
  • [1] Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial
    Akhondzadeh, Shahin
    Tabatabaee, Maryam
    Amini, Homayoun
    Abhari, Seyed Ali Ahmadi
    Abbasi, Seyed Hesamedin
    Behnam, Behnaz
    [J]. SCHIZOPHRENIA RESEARCH, 2007, 90 (1-3) : 179 - 185
  • [2] Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial
    Akhondzadeh, S
    Nejatisafa, AA
    Amini, H
    Mohammadi, MR
    Larijani, B
    Kashani, L
    Raisi, F
    Kamalipour, A
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2003, 27 (06): : 1007 - 1012
  • [3] Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Trial
    Usall, Judith
    Huerta-Ramos, Elena
    Iniesta, Raquel
    Cobo, Jesus
    Araya, Susana
    Roca, Mercedes
    Serrano-Blanco, Antoni
    Teba, Fernando
    Ochoa, Susana
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (11) : 1552 - 1557
  • [4] Levetiracetam as an Adjunctive Treatment for Mania: A Double-Blind, Randomized, Placebo-Controlled Trial
    Keshavarzi, Amir
    Sharifi, Aziz
    Jahangard, Leila
    Soltanian, Alireza
    Bruehl, Annette Beatrix
    Ahmadpanah, Mohammad
    Brand, Serge
    [J]. NEUROPSYCHOBIOLOGY, 2022, 81 (03) : 192 - 203
  • [5] Celecoxib adjunctive therapy for acute bipolarmania: a randomized, double-blind, placebo-controlled trial
    Arabzadeh, Somayeh
    Ameli, Niusha
    Zeinoddini, Atefeh
    Rezaei, Farzin
    Farokhnia, Mehdi
    Mohammadinejad, Payam
    Ghaleiha, Ali
    Akhondzadeh, Shahin
    [J]. BIPOLAR DISORDERS, 2015, 17 (06) : 606 - 614
  • [6] Simvastatin as an Adjunctive Therapy to Risperidone in Treatment of Autism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Moazen-Zadeh, Ehsan
    Shirzad, Fatemeh
    Karkhaneh-Yousefi, Mohammad-Ali
    Khezri, Rasoul
    Mohammadi, Mohammad-Reza
    Akhondzadeh, Shahin
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2018, 28 (01) : 82 - 89
  • [7] Resveratrol as adjunctive therapy in treatment of irritability in children with autism: A double-blind and placebo-controlled randomized trial
    Hendouei, Fatemeh
    Moghaddam, Hossein Sanjari
    Mohammadi, Mohammad Reza
    Taslimi, Negin
    Rezaei, Farzin
    Akhondzadeh, Shahin
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (02) : 324 - 334
  • [8] Lovastatin for the adjunctive treatment of schizophrenia: A preliminary randomized double-blind placebo-controlled trial
    Ghanizadeh, Ahmad
    Rezaee, Zahra
    Dehbozorgi, Sara
    Berk, Michael
    Akhondzadeh, Shahin
    [J]. PSYCHIATRY RESEARCH, 2014, 219 (03) : 431 - 435
  • [9] Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trial
    Ghazizadeh-Hashemi, Maryam
    Ghajar, Alireza
    Shalbafan, Mohammad-Reza
    Ghazizadeh-Hashemi, Fatemeh
    Afarideh, Mohsen
    Malekpour, Farzaneh
    Ghaleiha, Ali
    Ardebili, Mehrdad Eftekhar
    Akhondzadeh, Shahin
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2018, 232 : 127 - 133
  • [10] Adjunctive Bright Light Therapy for Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Trial
    Sit, Dorothy K.
    McGowan, James
    Wiltrout, Christopher
    Diler, Rasim Somer
    Dills, John
    Luther, James
    Yang, Amy
    Ciolino, Jody D.
    Seltman, Howard
    Wisniewski, Stephen R.
    Terman, Michael
    Wisner, Katherine L.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2018, 175 (02): : 131 - 139